← Evidence map

ReviewCancers2022

Current Status of CRISPR/Cas9 Application in Clinical Cancer Research: Opportunities and Challenges.

Saeed Rafii et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

27 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35205694